Small Bone Innovations, Inc. Raises $144 Million

* Raises Series D round of $108mm - one of the largest private equity capital
financings for an orthopedic company
* Raises Series C round of $36mm
* Retires $20 million credit facility

NEW YORK--(Business Wire)--
Small Bone Innovations, Inc. (SBi), an orthopedics company focused exclusively
on technologies and treatments for the small bones & joints, announced that it
has sold a total of $108 million of Series D Preferred Stock in a series of
private equity financings. The most recent of these financings closed in April
2009. The Series D financing is believed to be one of the largest ever private
equity capital investments in an orthopedics company.

The Series D funding included substantial investments from Goldman, Sachs & Co.,
Khazanah Nasional Berhad, the investment firm of the Government of Malaysia,
Malaysian Technology Development Corporation (MTDC), an integrated
Malaysian-based venture capital company, The Family Office of Bahrain, and
certain other substantial investors.

The Series D financing also included investments from existing investors Trevi
Health Ventures, NGN Capital, 3i Group, and TGap Ventures.

Anthony G. Viscogliosi, SBi`s Chairman & CEO, said: "In view of the extremely
difficult conditions in the global capital markets during the past 18 months,
the scope and quality of this investment round represent both a vote of
confidence in our business model and a recognition of the small bone & joint
market as the fastest growing sector in the orthopedics market. The size of the
investment in SBi is significant in view of the 51 percent decline this year in
medical device investing by venture capital firms - according to VentureSource
(a DowJones database)."

In addition to the Series D financing round, SBi completed in 2008 its Series C
Preferred Stock financing, raising a total of $36 million. This financing was
led by Viscogliosi Bros., LLC and included new investor Trevi Health Ventures,
and follow-on investments by NGN Capital, 3i, TGap Ventures and Axiom Venture
Partners.

The proceeds from the Series C and Series D financings were used in part to
complete the acquisition of the Scandinavian Total Ankle Replacement (S.T.A.R.®)
system from Waldemar Link GmbH & Co. KG of Hamburg, Germany, to fund operations,
to support the launch of the S.T.A.R. Ankle in the U.S. and to retire a $20
million credit facility, arranged in 2007 by Fortress Investment Group.

About Small Bone Innovations, Inc.

Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers,
LLC, (VB), a New York-based merchant banking firm that specializes in the
musculoskeletal/orthopedics sector. VB created SBi as the first company to focus
exclusively on small bones & joints. By integrating established companies and
professionals in the field, SBi offers a broad, clinically proven portfolio of
products and technologies to treat trauma and diseases in small bones & joints.
SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France and
Donaueschingen, Germany.

For more information on SBi, please visit: www.totalsmallbone.com

Forward-looking statements

This news release contains forward-looking statements as defined in the U.S.
Private Securities Litigation Reform Act of 1995. Readers are cautioned not to
place undue reliance on these forward-looking statements. Actual results may
differ materially from those indicated by these forward-looking statements as a
result of risks and uncertainties impacting SBi`s business including increased
competition; the ability of SBi to expand its operations and to attract and
retain qualified professionals; technological obsolescence; general economic
conditions; and other risks.

Small Bone Innovations, Inc.
Varun Gandhi, 212-583-0370 ext. 2126
vgandhi@totalsmallbone.com

Copyright Business Wire 2009